Mendus AB (publ) (IMMU.ST)

SEK 8.51

(-1.06%)

Eps Summary of Mendus AB (publ)

  • Mendus AB (publ)'s latest annual eps in 2023 was -4.40 SEK , down -598.41% from previous year.
  • Mendus AB (publ)'s latest quarterly eps in 2024 Q2 was -0.76 SEK , down -1740.19% from previous quarter.
  • Mendus AB (publ) reported an annual eps of -0.63 SEK in 2022, up 7.35% from previous year.
  • Mendus AB (publ) reported an annual eps of -0.68 SEK in 2021, up 39.29% from previous year.
  • Mendus AB (publ) reported a quarterly eps of -0.76 SEK for 2024 Q2, down -1740.19% from previous quarter.
  • Mendus AB (publ) reported a quarterly eps of -0.05 SEK for 2023 Q3, down -182.49% from previous quarter.

Annual Eps Chart of Mendus AB (publ) (2023 - 2009)

Historical Annual Eps of Mendus AB (publ) (2023 - 2009)

Year Eps Eps Growth
2023 -4.40 SEK -598.41%
2022 -0.63 SEK 7.35%
2021 -0.68 SEK 39.29%
2020 -1.12 SEK 33.73%
2019 -1.69 SEK 3.43%
2018 -1.75 SEK 38.6%
2017 -2.85 SEK 94.16%
2016 -48.78 SEK -2508.56%
2015 -1.87 SEK -23.03%
2014 -1.52 SEK -65.22%
2013 -0.92 SEK -124.39%
2012 -0.41 SEK -173.33%
2011 -0.15 SEK 0.0%
2010 -0.15 SEK -15.38%
2009 -0.13 SEK 0.0%

Peer Eps Comparison of Mendus AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -700.0%
Ziccum AB (publ) -1.54 SEK -185.714%
Modus Therapeutics Holding AB (publ) -1.01 SEK -335.644%
BioArctic AB (publ) 2.60 SEK 269.231%
Sprint Bioscience AB (publ) -0.01 SEK -69741.27%
Genovis AB (publ.) 0.94 SEK 568.085%
Intervacc AB (publ) -1.69 SEK -160.355%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -1900.0%
Active Biotech AB (publ) -0.17 SEK -2488.235%
Magle Chemoswed Holding AB (publ) 1.13 SEK 489.381%
Bio-Works Technologies AB (publ) -1.57 SEK -180.255%
Aptahem AB (publ) -0.05 SEK -9009.731%
Vicore Pharma Holding AB (publ) -3.22 SEK -36.646%
Kancera AB (publ) -0.80 SEK -450.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 55.779%
Fluicell AB (publ) -0.24 SEK -1733.333%
Saniona AB (publ) -1.29 SEK -241.085%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -2215.789%
Biovica International AB (publ) -2.14 SEK -105.607%
Spago Nanomedical AB (publ) -0.43 SEK -923.256%
AcouSort AB (publ) -1.29 SEK -241.085%
Xintela AB (publ) -0.13 SEK -3284.615%
Abliva AB (publ) -0.09 SEK -4767.257%
Egetis Therapeutics AB (publ) -1.27 SEK -246.457%
Karolinska Development AB (publ) 0.02 SEK 22100.0%
OncoZenge AB (publ) -1.36 SEK -223.529%
Amniotics AB (publ) -0.01 SEK -39900.0%
2cureX AB (publ) -1.85 SEK -137.838%
CombiGene AB (publ) -1.80 SEK -144.444%
Asarina Pharma AB (publ) -0.57 SEK -671.93%
Calliditas Therapeutics AB (publ) -8.69 SEK 49.367%
Camurus AB (publ) 7.78 SEK 156.555%
Corline Biomedical AB -0.08 SEK -5125.653%
IRLAB Therapeutics AB (publ) -3.43 SEK -28.28%
Isofol Medical AB (publ) -0.23 SEK -1813.043%
I-Tech AB 1.70 SEK 358.824%
Hansa Biopharma AB (publ) -15.83 SEK 72.205%
Cyxone AB (publ) -0.22 SEK -1900.0%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK -122.222%
Biosergen AB -0.60 SEK -633.333%
Cantargia AB (publ) -1.65 SEK -166.667%
NextCell Pharma AB -1.03 SEK -327.184%
Xspray Pharma AB (publ) -6.76 SEK 34.911%
Elicera Therapeutics AB (publ) -0.83 SEK -430.12%
Nanologica AB (publ) -2.05 SEK -114.634%
SynAct Pharma AB -6.64 SEK 33.735%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -1592.308%
Stayble Therapeutics AB (publ) -0.92 SEK -378.261%
LIDDS AB (publ) -0.63 SEK -598.413%
Lipum AB (publ) -4.45 SEK 1.124%
BioInvent International AB (publ) -5.02 SEK 12.351%
Alzinova AB (publ) -0.41 SEK -973.171%
Oncopeptides AB (publ) -1.96 SEK -124.49%
Pila Pharma AB (publ) -0.47 SEK -836.17%
Guard Therapeutics International AB (publ) -11.26 SEK 60.924%
Scandinavian ChemoTech AB (publ) -1.13 SEK -289.381%
Simris Alg AB (publ) -0.16 SEK -2650.0%
Diamyd Medical AB (publ) -1.60 SEK -175.0%
Xbrane Biopharma AB (publ) -1.27 SEK -246.457%
Ascelia Pharma AB (publ) -3.24 SEK -35.802%
Diagonal Bio AB (publ) -0.32 SEK -1275.0%